Abstract
The modulation by δ-, κ-, μ-, and opioid receptor like-1 (ORL1) agonists and antagonists ofl-glutamate (l-Glu) and γ-aminobutyric acid (GABA) efflux from superfused rat cerebrocortical synaptosomes was studied. Tetrodotoxin (0.5 μM) inhibited the spontaneous efflux of both transmitters by 20%. Ca2+ omission decreased GABA and facilitated l-Glu efflux. The neurotransmitter overflow evoked by K+ concentrations in the 7.5- to 10-mM range was largely Ca2+ dependent and tetrodotoxin sensitive. Neither the δ-receptor agonist deltorphin (up to 0.3 μM) nor the ORL1 receptor agonist nociceptin (up to 1 μM) significantly affected either spontaneous or K+-evoked neurotransmitter efflux. Conversely, the ORL1 ligand [Phe1(CH2-NH)Gly2]nociceptin(1–13)NH2(0.3 μM) caused a naloxone-sensitive inhibition of bothl-Glu- and GABA-stimulated overflow. The κ-receptor agonist (−)-U50,488 failed to modulate spontaneous l-Glu and GABA efflux. However, it similarly inhibited the K+-evoked overflow of both neurotransmitters (EC50 ∼100 nM; Emax∼25–30% inhibition) in a norbinaltorphimine-sensitive manner. The selective μ-receptor agonist endomorphin 1 inhibited both spontaneous (EC50 ∼50 nM) and K+-evoked (EC50∼10 nM; Emax ∼50% inhibition)l-Glu efflux in a naloxone-sensitive manner. Conversely, it significantly inhibited only K+-evoked GABA efflux (EC50 ∼10 nM), although with a lower maximal effect (Emax ∼25–30% inhibition). It is concluded that, in the rat cerebral cortex, l-Glu and GABA efflux from nerve terminals is under the direct inhibitory control of κ- and μ- (but not δ- or ORL1) receptors. Because glutamatergic terminals emerged as a preferential target of μ-receptor agonists, the activation of this receptor may advocate both relevant analgesic and neuroprotective effects.
Footnotes
-
Send reprint requests to: Simone Sbrenna, Department of Experimental and Clinical Medicine, Section of Pharmacology, via Fossato di Mortara 17-19, 44100 Ferrara, Italy. E-mail:mri{at}ifeuniv.unife.it
-
↵1 This work was supported by Centro Nazionale Ricerche Grant 9704432-CT-04.
- Abbreviations:
- ORL1
- opioid receptor like-1
- CNS
- central nervous system
- NE
- norepinephrine
- DT1
- deltorphin I
- EM1
- endomorphin 1
- [F/G]NC(1–13)NH2
- [Phe1(CH2-NH)Gly2]NC(1–13)NH2
- NC
- nociceptin
- Nal
- nalaxone
- norBNI
- norbinaltorphimine
- Received May 10, 1999.
- Accepted September 7, 1999.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|